Indivior Pharmaceuticals, Inc. (INDV) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Indivia PLC Q1 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you will need to press star 1, 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1, 1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your host today, Jason Thompson. Please go ahead. Thanks, Heidi, and good morning and good afternoon, everyone. Before we begin, I need to remind everyone that on today's call, we may make forward-looking statements that are subject to risks and uncertainties, and that actual results may differ materially. We list the factors that may cause our results to be materially different on slide two of this presentation. We also may refer to non-GAAP measures, the reconciliations for which may also be found in the appendix to the presentation that is now posted on our website at indivior.com. I'll now turn the call over to Mark Crossley, our CEO. Thanks, Jason. Good morning, good afternoon, everyone. Thanks for joining us on this call to discuss our financial and business performance during the first quarter of 2025. I'll start with a brief overview of the quarter before handing it over to Ryan, our chief financial officer, to discuss the financials. We'll then conclude with a Q&A session during which we'll be joined by Christian Heidbreder, our chief scientific officer. Turning to slide four, overall results in the first quarter were in line with our expectations and consistent with our full year 2025 outlook. ...